LB4. Efficacy and Safety of Cefiderocol vs. High-Dose Meropenem in Patients with Nosocomial...

Por Wunderink, Richard G, Wunderink, Richard G, Matsunaga, Yuko, Ari, Mari, Ariyasu, Mari, Echols, Roger, Echols, Roger, Menon, Anju, Den Nagata, Tsutae, Den Nagata, Tsutae
Publicado no Open Forum Infect Dis (2019)

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

Por Long, G. V., Flaherty, K. T., Stroyakovskiy, D., Gogas, H., Levchenko, E., de Braud, F., Larkin, J., Garbe, C., Jouary, T., Hauschild, A., Chiarion-Sileni, V., Lebbe, C., Mandalà, M., Millward, M., Arance, A., Bondarenko, I., Haanen, J. B. A. G., Hansson, J., Utikal, J., Ferraresi, V., Mohr, P., Probachai, V., Schadendorf, D., Nathan, P., Robert, C., Ribas, A., Davies, M. A., Lane, S. R., Legos, J. J., Mookerjee, B., Grob, J.-J.
Publicado no Ann Oncol (2017)

The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical...

Por Schmader, Kenneth E, Levin, Myron J, Grupping, Katrijn, Matthews, Sean, Butuk, David, Chen, Michael, Idrissi, Mohamed El, Fissette, Laurence A, Fogarty, Charles, Hartley, Paul, Klein, Nicola P, Nevarez, Max, Uusinarkaus, Kari, Oostvogels, Lidia, Curran, Desmond
Publicado no J Gerontol A Biol Sci Med Sci (2019)

Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC)

Por Rovers, Koen P, Lurvink, Robin J, Wassenaar, Emma CE, Kootstra, Thomas JM, Scholten, Harm J, Tajzai, Rudaba, Deenen, Maarten J, Nederend, Joost, Lahaye, Max J, Huysentruyt, Clément JR, van ’t Erve, Iris, Fijneman, Remond JA, Constantinides, Alexander, Kranenburg, Onno, Los, Maartje, Thijs, Anna MJ, Creemers, Geert-Jan M, Burger, Jacobus WA, Wiezer, Marinus J, Boerma, Djamila, Nienhuijs, Simon W, de Hingh, Ignace HJT
Publicado no BMJ Open (2019)

Safety of two doses of an inactivated hepatitis a vaccine given 6 months apart in healthy toddlers...

Por Shi, Nianmin, Rasuli, Anvar, Thollot, Yaël
Publicado no Hum Vaccin Immunother (2018)

2490. A Phase 1, Randomized, Observer Blind, Antigen and Adjuvant Dosage Finding Study to Evaluate...

Por Otten, Gillis, Matassa, Vince, Ciarlet, Max, Leav, Brett
Publicado no Open Forum Infect Dis (2018)

Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)

Por Moehler, M., Heo, J., Lee, H.C., Tak, W.Y., Chao, Y., Paik, S.W., Yim, H.J., Byun, K.S., Baron, A., Ungerechts, G., Jonker, D., Ruo, L., Cho, M., Kaubisch, A., Wege, H., Merle, P., Ebert, O., Habersetzer, F., Blanc, J.F., Rosmorduc, Olivier, Lencioni, R., Patt, R., Leen, A.M., Foerster, F., Homerin, M., Stojkowitz, N., Lusky, M., Limacher, J.M., Hennequi, M., Gaspar, N., McFadden, B., De Silva, N., Shen, D., Pelusio, A., Kirn, D.H., Breitbach, C.J., Burke, J.M.
Publicado no Oncoimmunology (2019)

Endometrial receptivity enhancement through induced injury and repair during ovarian stimulation: the Receptivity Enhancement by Follicular-phase Renewal after Endometrial ScratcHing (REFRESH) trial protocol

Por Santos-Ribeiro, Samuel, Mackens, Shari, Tournaye, Herman, Blockeel, Christophe, Stoop, Dominic
Publicado no Hum Reprod Open (2017)

Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD

Por Buitelaar, Jan K., Trott, Götz-Erik, Hofecker, Maria, Waechter, Sandra, Berwaerts, Joris, Dejonkheere, Joachim, Schäuble, Barbara
Publicado em 2012

The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer

Por Powles, T., Kayani, I., Blank, C., Chowdhury, S., Horenblas, S., Peters, J., Shamash, J., Sarwar, N., Boletti, K., Sadev, A., O'Brien, T., Berney, D., Beltran, L., Haanen, J., Bex, A.
Publicado em 2011

Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment...

Por Cardone, Claudia, Martinelli, Erika, Troiani, Teresa, Sforza, Vincenzo, Avallone, Antonio, Nappi, Anna, Montesarchio, Vincenzo, Andreozzi, Francesca, Biglietto, Maria, Calabrese, Filomena, Bordonaro, Roberto, Cordio, Stefano, Bregni, Giacomo, Febbraro, Antonio, Garcia-Carbonero, Rocio, Feliu, Jaime, Cervantes, Andrés, Ciardiello, Fortunato
Publicado no ESMO Open (2019)

Exploratory analysis of front-line therapies in REVEL: a randomised phase 3 study of ramucirumab...

Por Garon, Edward B, Scagliotti, Giorgio Vittorio, Gautschi, Oliver, Reck, Martin, Thomas, Michael, Iglesias Docampo, Lara, Kalofonos, Haralabos, Kim, Joo-Hang, Gans, Steven, Brustugun, Odd Terje, Orlov, Sergey V, Cuyun Carter, Gebra, Zimmermann, Annamaria H, Oton, Ana B, Alexandris, Ekaterine, Lee, Pablo, Wolff, Katharina, Stefaniak, Victoria Jennifer, Socinski, Mark A, Pérol, Maurice
Publicado no ESMO Open (2020)

A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel...

Por Lee, Keun-Wook, Kim, Bum Jun, Kim, Mi-Jung, Han, Hye Sook, Kim, Jin Won, Park, Young Iee, Park, Sook Ryun
Publicado no Cancer Res Treat (2017)

Comparison of the pharmacokinetics, safety, and immunogenicity of MSB11022, a biosimilar of adalimumab, with Humira(®) in healthy subjects

Por Hyland, Elizabeth, Mant, Tim, Vlachos, Pantelis, Attkins, Neil, Ullmann, Martin, Roy, Sanjeev, Wagner, Volker
Publicado no Br J Clin Pharmacol (2016)

Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings

Por Cooper, David A., Heera, Jayvant, Ive, Prudence, Botes, Mariette, Dejesus, Edwin, Burnside, Robert, Clumeck, Nathan, Walmsley, Sharon, Lazzarin, Adriano, Mukwaya, Geoffrey, Saag, Michael, van Der Ryst, Elna
Publicado em 2014

Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines

Por Capeding, Maria Rosario Z., Gonzales, Maria Liza Antoinette M., Dhingra, Mandeep Singh, D'Cor, Naveena Aloysia, Midde, Venkat Jayanth, Patnaik, Badri Narayan, Thollot, Yaël, Desauziers, Eric
Publicado no Hum Vaccin Immunother (2017)

Magnetic Resonance–Guided Focused Ultrasound for Patients With Painful Bone Metastases: Phase III Trial Results

Por Hurwitz, Mark D., Ghanouni, Pejman, Kanaev, Sergey V., Iozeffi, Dmitri, Gianfelice, David, Fennessy, Fiona Mary, Kuten, Abraham, Meyer, Joshua E., LeBlang, Suzanne D., Roberts, Ann, Choi, Junsung, Larner, James M., Napoli, Alessandro, Turkevich, Vladimir G., Inbar, Yael, Tempany, Clare Mary C., Pfeffer, Raphael M.
Publicado em 2014

Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer

Por Diéras, Véronique, Rugo, Hope S, Schnell, Patrick, Gelmon, Karen, Cristofanilli, Massimo, Loi, Sherene, Colleoni, Marco, Lu, Dongrui R, Mori, Ave, Gauthier, Eric, Huang Bartlett, Cynthia, Slamon, Dennis J, Turner, Nicholas C, Finn, Richard S
Publicado no J Natl Cancer Inst (2018)

ACTR-19. A MULTICENTER PILOT PHASE II STUDY OF CONTINUING TMZ WITH THE ADDITION OF DISULFIRAM AND COPPER FOR REFRACTORY GLIOBLASTOMA

Por Huang, Jiayi, Chaudhary, Rehka, Cohen, Adam, Fink, Karen, Godlust, Samuel, Boockvar, John, Chinnaiyan, Prakash, Marcus, Stephen, Campian, Jian
Publicado no Neuro Oncol (2018)

Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China

Por Chen, Nan, Qian, Jiaqi, Chen, Jianghua, Yu, Xueqing, Mei, Changlin, Hao, Chuanming, Jiang, Gengru, Lin, Hongli, Zhang, Xinzhou, Zuo, Li, He, Qiang, Fu, Ping, Li, Xuemei, Ni, Dalvin, Hemmerich, Stefan, Liu, Cameron, Szczech, Lynda, Besarab, Anatole, Neff, Thomas B., Peony Yu, Kin-Hung, Valone, Frank H.
Publicado no Nephrol Dial Transplant (2017)